![Stephen Basso](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Basso
Financieel Directeur/CFO bij
INNOVIVA, INC.
Vermogen: 2 M $ op 30-06-2026
Profiel
Stephen Basso currently serves as Treasurer & Director at La Jolla Pharmaceutical Co., Chief Financial Officer at Innoviva, Inc. since 2023, and Treasurer at Tetraphase Pharmaceuticals, Inc. Formerly, Mr. Basso was Vice President-North America Commercial at Alexion Pharmaceuticals, Inc. from 2016 to 2017, Chief Financial Officer & Senior VP-Finance at Inozyme Pharma, Inc. from 2020 to 2021, and Chief Operating & Financial Officer at Cybrexa, Inc. Education includes an MBA from Boston College and an undergraduate degree from Providence College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INNOVIVA, INC. 0,12% | 20-05-2026 | 88.571 ( 0,12% ) | 2 M $ | 30-06-2026 |
Actieve functies van Stephen Basso
| Bedrijven | Functie | Begin |
|---|---|---|
| INNOVIVA, INC. | Financieel Directeur/CFO | 21-08-2023 |
| LA JOLLA PHARMACEUTICAL COMPANY | Directeur/Bestuurslid | - |
| TETRAPHASE PHARMACEUTICALS, INC. | Treasurer | - |
Eerdere bekende functies van Stephen Basso
| Bedrijven | Functie | Einde |
|---|---|---|
| INOZYME PHARMA, INC. | Financieel Directeur/CFO | 14-05-2021 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-05-2017 |
Cybrexa, Inc.
 Cybrexa, Inc. BiotechnologyHealth Technology Develops molecule DNA repair inhibitors that directly target the tumor microenvironment | Financieel Directeur/CFO | - |
Opleiding van Stephen Basso
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
60
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Providence College
 Providence College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inozyme Pharma, Inc.
 Inozyme Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
Cybrexa, Inc.
Cybrexa, Inc. BiotechnologyHealth Technology Develops molecule DNA repair inhibitors that directly target the tumor microenvironment | Health Technology |
